Clinical Trial Update: Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ETC-1002 vs placebo in patients on ongoing statin therapy for hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• ETC-1002 (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED